Q1 2024 · 13F-HR
Blue Owl Capital Holdings LPholdings as filed
Filed 2024-05-15 · accession 0000950123-24-005559
$500.6M
Reported value
45
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 770700102 | HOOD | ROBINHOOD MKTS INC | $54.0M | 10.8% | 4,237,409 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $49.8M | 9.96% | 2,924,842 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $44.8M | 8.94% | 3,004,199 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $41.7M | 8.33% | 2,461,350 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $32.0M | 6.39% | 1,447,401 | Common | SOLE |
| 69121K104 | OBDC | BLUE OWL CAPITAL CORPORATION | $31.5M | 6.28% | 2,045,070 | Common | SOLE |
| 49845K101 | KVYO | KLAVIYO INC | $30.5M | 6.10% | 1,198,270 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $30.3M | 6.06% | 3,994,468 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $19.1M | 3.81% | 2,826,028 | Common | SOLE |
| 29977X105 | EVCM | EVERCOMMERCE INC | $15.5M | 3.09% | 1,641,929 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $14.7M | 2.94% | 3,122,499 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $12.5M | 2.50% | 268,238 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $11.4M | 2.28% | 172,633 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $9.7M | 1.94% | 1,270,027 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $9.7M | 1.93% | 155,260 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $9.1M | 1.81% | 1,673,877 | Common | SOLE |
| 888787108 | TOST | TOAST INC | $8.0M | 1.61% | 322,578 | Common | SOLE |
| 29788T103 | ETWOGBP | E2OPEN PARENT HOLDINGS INC | $7.3M | 1.46% | 1,650,943 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $7.0M | 1.40% | 541,080 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $5.6M | 1.12% | 2,829,712 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $5.5M | 1.10% | 3,891,118 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $5.0M | 1.00% | 100,000 | Common | SOLE |
| 24703L202 | DELL | DELL TECHNOLOGIES INC | $4.7M | 0.94% | 41,245 | Common | SOLE |
| 68217N105 | — | OMEGA THERAPEUTICS INC | $3.9M | 0.77% | 1,055,882 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $3.7M | 0.74% | 875,000 | Common | SOLE |
| 25460G716 | LABDUSD | DIREXION SHS ETF TR | $3.6M | 0.71% | 490,000 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $3.6M | 0.71% | 13,319 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $3.5M | 0.70% | 695,000 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $3.3M | 0.66% | 733,568 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $3.2M | 0.65% | 100,000 | Common | SOLE |
| 29286M113 | — | ENGENE HOLDINGS INC | $2.7M | 0.53% | 511,177 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $2.6M | 0.53% | 864,822 | Common | SOLE |
| 10576N102 | BRZE | STARWOOD PROPERTY TRUST | $2.4M | 0.47% | 116,153 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $1.8M | 0.36% | 340,855 | Common | SOLE |
| 833445109 | SNOW | SNOWFLAKE INC | $1.3M | 0.25% | 7,819 | Common | SOLE |
| 37637K108 | GTLB | GITLAB, INC | $1.2M | 0.24% | 20,706 | Common | SOLE |
| 09352U108 | BLND | BLEND LABS INC | $1.2M | 0.23% | 361,587 | Common | SOLE |
| 38046W204 | GOCO | GOHEALTH INC | $875,120 | 0.17% | 83,264 | Common | SOLE |
| 25058X105 | — | DESKTOP METAL INC | $660,000 | 0.13% | 750,000 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $647,944 | 0.13% | 350,240 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $439,750 | 0.09% | 25,000 | Common | SOLE |
| 74019P207 | DTIL | PRECISION BIOSCIENCES INC | $274,183 | 0.05% | 20,220 | Common | SOLE |
| 31189Y103 | — | FATHOM DIGITAL MFG CORP | $230,500 | 0.05% | 50,000 | Common | SOLE |
| 90353T100 | UBER | GERON CORPORATION | $78,929 | 0.02% | 23,918 | Common | SOLE |
| G63290103 | PLMWF | PLUM ACQUISITION CORP III | $0 | — | 666,666 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.